Related Experiment Video
Updated: Apr 16, 2026
08:00
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Published on: October 11, 2019
8.0K
Identification and validation of gene module associated with lung cancer through coexpression network analysis
Rong Liu1, Yu Cheng1, Jing Yu1
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, P.R. China.
Gene
|March 11, 2015
Summary
Researchers identified a key gene module and lung cancer-specific hub network (LCHN) involved in lung cancer regulation. This network shows potential as biomarkers and therapeutic targets for lung cancer.
Area of Science:
- Genomics and Bioinformatics
- Cancer Biology
- Molecular Oncology
Background:
- Lung cancer exhibits heterogeneous biology driven by complex gene interactions.
- Understanding gene networks is crucial for advancing lung cancer tumor biology knowledge.
Purpose of the Study:
- To investigate the role of gene networks in lung cancer regulation using weighted gene coexpression network analysis.
- To identify potential biomarkers and therapeutic targets for lung cancer.
Main Methods:
- Weighted gene coexpression network analysis was performed on 58 paired tumorous and non-tumorous lung samples.
- Six gene modules were identified based on coexpression patterns.
- A lung cancer-specific hub network (LCHN) was derived from a key module enriched for "response to wounding" genes.
Main Results:
- One gene module showed significantly higher expression in normal lung tissue compared to lung cancer, validated across six datasets.
- The identified LCHN, comprising 15 genes, robustly separated lung cancer from normal tissues (91.7%-98.5% accuracy) using machine learning.
- Eight genes within the LCHN are directly associated with lung cancer.
Conclusions:
- A significant gene module and LCHN associated with lung cancer were identified.
- The LCHN presents potential as candidate biomarkers and therapeutic targets for lung cancer.
- This integrated transcriptomic analysis offers a novel strategy for identifying oncogenic drivers in lung cancer.
